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Abstract 
Background: Gallstones being one of the common 
digestive disorders, are a major burden on public 
health resources. There is a high prevalence of 
gallstones in HCV positive patients in USA. There is 
a second highest prevalence of HCV infection in 
Pakistan after Egypt. 
Objectives: To determine the frequency of 
gallstones in Anti-HCV Antibody positive patients 
at a tertiary care hospital of Larkana. 
Methods: This is an Observational Cross-sectional 
study. Study was carried out from December 2017 to 
December 2018 at Department of Medicine, Chandka 
Medical College Teaching Hospital, Larkana. 
Patients who visited medical OPD for treatment of 
Hepatitis C had abdominal ultrasonological 
examination performed by a senior consultant 
radiologist, who especially looked for gallstones. 
Diagnosis of gallstones was confirmed by 
radiologist. 
Results: Total 160 patients were included in study, 
97 (60.6%) of whom were male and 63 (39.4%) were 
female. Gallstones were present in 28 (17.5%) cases. 
Gallstones positive males were 11 (11.3%) and 
females were 17 (27%). Gallstones were found to be 
more common in women. 
Conclusion: HCV infection may be a risk factor 
for developing gallstones in younger patients.  
Keywords: Gallstones, HCV, Extrahepatic 
Manifestations.  
 
Introduction 
Gallstones are one of the most common digestive 
disorders, putting a major burden on public health 
resources.1 Prevalence of gallstone in US population is  
around 14.1%.2 The prevalence of gallstones and 
cholecystectomy due to gallstones in USA is 10.5% and 
27.9% in HCV positive men and women respectively. 
Therefore, the overall prevalence of gallstones in HCV 
positive cases is 19.2%.3 In Pakistan Chronic Hepatitis 
C (CHC) infection is a major cause of chronic liver 
disease4.There is a second highest prevalence of HCV 
infection in Pakistan (4.7%) after Egypt (15.5%).5 
Global estimation of chronic HCV is about 170 million 
persons, and incidence is about 3 to 4 million persons 
each year.6 This causes chronic hepatitis in 80% of 
cases leading to cirrhosis and hepatocellular 
carcinoma.2 Apart from this, chronic HCV infection 
leads to histologic changes in bile duct and hepatic 
steatosis.7,8 Considering the clinical co-relation of HCV 
infection and risk of gall stone formation, the rationale 
for this study was to see the frequency of gallstones in 
HCV positive patients in our local population. The 
reported risk of gallstones is high in Chronic Hepatitis 
C patients as mentioned above. This study aims to lash 
at the appreciated frequency of gallstones in Chronic 
Hepatitis C patients. 
 
Patients and Methods 
This cross-sectional observational study was 
conducted at Medical Unit I of Chandka Medical 
College Teaching Hospital Larkana from December 
2017 to December 2018. All the subjects of either 
gender and age >12 years, having HCV infection 
evidenced by 2nd generation of ELISA method, 
attending medical OPD were included in the study by 
non-probability purposive sampling technique. From 
each patient thorough medical history, detailed 
physical examination and selected laboratory 
investigations were taken to fulfill the inclusion and 
exclusion criteria. Patients using drugs like oral 
contraceptive pills, octreotide, clofibrate and 
ceftriaxone or having co-morbidities like diabetes 
mellitus, liver cirrhosis and obesity were excluded 
from the study. Obese patients were excluded by using 
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BMI scoring system according to National Institute of 
Health (NIH)9. These conditions were excluded from 
study because all of the above risk factors are well-
known to gall stone formation. Informed consent has 
been obtained from all cases included in the study. The 
study was approved by the Ethical Review Committee. 
Abdominal Ultrasonographic examination was 
performed by a consultant radiologist in the 
department of radiology by using SSA 160 Toshiba 
machine, with 3.5 MHz transducer. Radiological 
diagnosis was confirmed after sonic echoes within the 
gallbladder and post acoustic shadowing.  
Data has been analyzed on computer using SPSS 
version 16.0 software Program. Descriptive statistics 
like frequency and percentages have been computed 
for gender and outcome i.e. presence or absence of gall 
stone. Mean ± SD (standard deviation) have been 
calculated for age. Frequency of gall stones have also 
been presented according to gender and age. 
Stratification has been done on age, gender and 
duration of hepatitis C to control the effect of these on 
outcome. 
 
Results 
Total of 160 patients were enrolled in 1 year. 97(60.6%) 
of them were male and 63 (39.4%) were female. Mean 
age of patients who participated in study was 
35.9±10.9 years. Gallstones were present in 28(17.5%) 
cases. Out of them 11(11.3%) were males and 17(27%) 
females. We divided patients into five age groups; 
group 1 less than 20 years of age, group 2 between 20-
29 years of age, group 3 between 30-39 years, group 4 
40-49 years and group 5 more than 49 years of age. 
Gall stones were found as 0 (0%) in group 1, 03 (11%) 
in group 2, 12(43%)in group 3,08(28%) in group 4, 
05(18%) in group 5. We divided the patients into four 
groups on the basis of duration of Anti HCV Antibody 
positivity. Group 1 comprises of 72 patients who were 
not aware of Anti HCV Antibody positivity 
previously.  Among them 13(46%) were found to have 
gall stones. Group 2 comprises of 19 patients who were 
Anti HCV Antibody positive for less than 6 months. It 
comprises of 02(7%) patients with gall stones. Group 3 
comprises of 40 patients who were Anti HCV 
Antibody positive for duration between 6 to 12 
months. It comprises of 05(18%) patients with gall 
stones. Group 4 comprises of 29 patients who were 
Anti HCV Antibody positive for more than 12 months. 
It comprises of 08 (29 %) patients with gall stones. 
When data was analyzed, we found 28(17.5) cases in 
whom gallbladder wall thickening was seen by 
sonologist on ultrasonological examination. Among 
them 17(17.5%) were male and 11(17.5%) female. 
 
Table I: Basic characteristics of study subjects 
S. 
No. 
Variable N % 
1 Gender 
Male 
Female 
 
97 
63 
 
60.6 
39.4 
2 Gall stones  
Present  
Absent  
 
28 
132 
 
17.5 
82.5 
3 Gall bladder wall 
thickening 
Present 
Absent 
 
 
28 
132 
 
 
17.5 
82.5 
 
Table II: Association of Gall stones with different 
variables. 
S. 
No. 
Variable Gall stones 
Present Absent 
1 Gender  
Male 
Female 
 
11 (39.29%) 
17 (60.71%) 
 
86 (65.16%) 
46 (34.84%) 
2 Age (years) 
<20 
20-29 
30-39 
40-49 
>49 
 
0 (0%) 
03 (10.71%) 
12 (42.86%) 
08 (28.57%) 
05 (17.86%) 
 
07 (5.30%) 
38 (28.79%) 
48 (36.36%) 
21 (15.91%) 
18 (13.64%) 
3 Duration of 
HCV 
infection  
Not known 
<6 months 
6-12 months 
>12 months 
 
 
 
13 (46.42%) 
2 (7.14%) 
5 (17.86%) 
8 (28.58%) 
 
 
 
59 (44.7%) 
17 (12.88%) 
35 (26.51%) 
21 (15.91%) 
 
 
Discussion 
Gallstones are one of the most common, costly and a 
major health burden of the digestive diseases2. 
Prevalence of gallstone markedly varies with race and 
ethnic groups.10 Common mechanism in gallstone 
formation is impaired gallbladder function and bile 
composition.11 It is reported to be present in 10-15 % of 
adult population in USA.12 While in Pakistan some 
hospital-based studies show variations in frequency of 
gall stones. Large population-based studies are not 
seen to calculate the prevalence of gallstones in 
different parts of country. Ultrasonography is a quick, 
cheap and non-invasive method of visualizing the 
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gallbladder.13 The risk of gallstones increases with 
age.13 In addition to age, gender, and race/ethnicity, 
other potential risk factors for gallstones include 
obesity,10 pregnancy,14 oral contraceptive pills15 and 
diabetes mellitus.10 However, risk factors for gallstone 
development differ among both genders and these 
variables may be present inconsistently.13 HCV is a 
well-known cause of acute and chronic hepatitis C. It 
has several extra hepatic manifestations. 40-74% of 
patients infected with HCV may develop one of the 
extra hepatic manifestations during disease course16. 
The mechanism of gallstone formation in HCV 
positive cases is direct infection of gallbladder by 
HCV. Loriot et al successfully witnessed gallbladder 
epithelium involvement by HCV infection.17 HCV 
RNA and hepatitis C antigens are found at autopsy of 
hepatitis C infected patients.18 So, the proposed 
mechanism of gallstone formation by HCV infection is 
by this modality and altered function in gallbladder 
mucosa. Several investigators have also noted that the 
risk of gallstones varies according to the etiology of 
cirrhosis.20 Cirrhosis due to hepatitis C is associated 
with decreased gallbladder motility according to some 
studies.21 Our study confirms the presence of 
gallstones among patients who were suffering from 
HCV infection as it has been confirmed by Bini et al03 
in a population-based study conducted in United 
States of America. Another study form Taiwan21 on 
patients who visited the hospital for general medical 
checkup also confirmed gallstones on ultrasound. In 
our study gallstones were more commonly seen in 30-
40 years of age, which is not a common age to develop 
gallstones in general population. Similarly, peak age of 
gallstones in HCV positive cases is seen in between 30-
40 years in Taiwanese study.21 Patients in our study 
might have acquired HCV infection earlier in their life 
which could be a reason for developing gallstones at a 
younger age.  Bini et al3 found males to develop gall 
stones more commonly than females. It is likely that 
female gender is already a well-known risk factor for 
gallstone formation. In this study gallstones were 
found to be more common in a group of patients who 
did not know about the duration of their infection. It 
was also noted more commonly in a group in whom 
HCV infection was present for more than one year of 
duration. It could be possible that the group who did 
not know about the duration of infection, may have 
acquired it for a prolong period of time and patients 
did not know because of asymptomatic nature of HCV 
infection in majority of patients.  So based on these 
results, we can say that the chances of developing 
gallstones may be more in patients who have acquired 
HCV infection for a prolonged period of time. 
Furthermore, when we were analyzing the results, we 
found gallbladder wall thickening in the reports of 
ultrasonological examination in some patients. It is 
considered as an initial indicator towards gallstone 
formation in future.22 So, these patients might have 
started the process of developing gallstones. 
Furthermore, gallstones are found in 30% cases of 
HCV related cirrhosis.23 So early screening for 
gallstones in HCV infected patients will not only 
reduce the chances of serious complications but it can 
also improve the life quality and cost burden on 
treatment of these patients. However, limitations on 
our results are that the exact duration of acquiring 
HCV infection may not be exactly known to the 
patients because of asymptomatic nature of HCV 
infection. We found out the duration of HCV infection 
only by taking history from the patient. Our results 
could not be generalized due to cross-sectional nature 
of the study, which cannot show causal relationship 
between HCV infection and gall stones. 
Our study is of small sample size so large sample size 
studies with lower limitations are proposed to get 
more valuable results.  
 
Conclusion 
HCV infection is a risk factor for developing 
gallstones. Duration of HCV positivity is directly 
proportional to the development of gallstones. 
Gallbladder wall thickening could be considered an 
initial indicator to develop gallstones in future. 
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